Skip to main content

9 Result(s)

within Shigeo Isaka Remove this filter

and

  1. No Access

    Article

    Prophylactic chemotherapy with intravesical instillation of Adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer

    The Japanese Urological Cancer Research Group for Adriamycin has conducted a series of clinical trials to investigate the efficacy and safety of prophylactic intravesical chemotherapy for superficial bladder c...

    Koji Obata, Yasuo Ohashi, Hideyuki Akaza… in Cancer Chemotherapy and Pharmacology (1994)

  2. No Access

    Article

    Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: Report of a case

    A huge rectosigmoidal cancer which extended into the urinary bladder in a 64-year-old man is herein described. The tumor occupied the pelvic and lower abdominal cavities, while the rectosigmoid was totally obs...

    Shigeru Fujimoto, Makoto Takahashi, Kokuriki Kobayashi, Masanobu Kure… in Surgery Today (1993)

  3. No Access

    Article

    The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

    A multicentric randomised trial was conducted for the purpose of investigating the efficacy of intravesical chemoprophylaxis of superficial bladder cancer. A total of 443 patients (number of evaluable patients...

    Yosuke Matsumura, Hideyuki Akaza, Shigeo Isaka… in Cancer Chemotherapy and Pharmacology (1992)

  4. No Access

    Article

    Sequential instillation therapy with mitomycin C and Adriamycin for superficial bladder cancer

    Intravesical chemotherapy involving the sequential instillation of mitomycin C (MMC) and Adriamycin (ADM) was performed in 40 patients with superficial bladder cancer (pathological stages Ta and T1). In all, 2...

    Shigeo Isaka, Tatsuya Okano, Kohichi Abe… in Cancer Chemotherapy and Pharmacology (1992)

  5. No Access

    Article

    Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese urological cancer research group for Adriamycin

    Long-term results were analyzed in terms of tumor progression and survival in patients with superficial bladder cancer who were enrolled in the second intravesical chemoprophylactic study of the Japanese Urolo...

    Hideyuki Akaza, Kenkichi Koiso, Toshihiko Kotake… in Cancer Chemotherapy and Pharmacology (1992)

  6. No Access

    Chapter

    Clinical Course of Bone Metastasis from Prostatic Cancer Following Endocrine Therapy: Examination with Bone X-Ray

    X-ray findings of bone metastatic lesions from 81 cases of stage D2 prostatic cancer were examined before and following endocrine therapy. Untreated lesions were classified into five types; osteoblastic (15%),...

    Jun Shimazaki, Tsutou Higa, Susumu Akimoto… in Prostate Cancer and Bone Metastasis (1992)

  7. No Access

    Article

    Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C

    A multicenter trial for postoperative prophylaxis of superficial Ta-T1, G1-G2 bladder cancer was performed. Intravesical instillation using either 20–30 mg adriamycin or 20 mg mitomycin C per dose was carried out...

    Shigeo Isaka, Tatsuya Okano, Jun Shimazaki… in Cancer Chemotherapy and Pharmacology (1987)

  8. No Access

    Article

    Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer

    The Japanese Urological Cancer Research Group has conducted three randomized clinical studies on intravesical chemoprophylaxis of superficial bladder cancers. This paper presents a comparative analysis of the ...

    Hideyuki Akaza, Shigeo Isaka, Kenkichi Koiso… in Cancer Chemotherapy and Pharmacology (1987)

  9. No Access

    Article

    Phase III trial of The Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder

    A non-randomized clinical study on systemic combination chemotherapy was conducted by the Japanese Urological Cancer Research Group for Adriamycin to compare the effectiveness of CAP (cyclophosphamide 200–500 ...

    Akio Maru, Hideyuki Akaza, Shigeo Isaka… in Cancer Chemotherapy and Pharmacology (1987)